Cryosite

Cryosite Profit per Employee

The Profit per Employee of Cryosite (CTE.AX) as of Oct 28, 2026 is 65,735.29 AUD. In the previous year, Profit per Employee was 55,411.76 AUD — a change of 18.63% (higher).

Profit per Employee

65,735.29AUD

YoY

18.63%

Last updated:

Profit per Employee of Cryosite is 2026 65,735.29 AUD. Profit per Employee of Cryosite was 2025 55,411.76 AUD. It decreases by 18.63% higher compared to the previous year.

The Cryosite Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2019
-16,622.26 AUD
Jan 1, 2020
43,534.68 AUD
Jan 1, 2021
19,193.35 AUD
Jan 1, 2022
40,112.68 AUD
Jan 1, 2023
41,441.18 AUD
Jan 1, 2024
54,117.65 AUD
Jan 1, 2025
55,411.76 AUD
Jan 1, 2026
65,735.29 AUD
The Cryosite Profit per Employee history
YEARProfit per EmployeeYoY
65,735.29AUD+18.63%
55,411.76AUD+2.39%
54,117.65AUD+30.59%
41,441.18AUD+3.31%
40,112.68AUD+108.99%
19,193.35AUD-55.91%
43,534.68AUD-361.91%
-16,622.26AUD+130.96%
-7,196.94AUD+72.19%
-4,179.68AUD-146.98%
8,896.06AUD-33.55%
13,387.35AUD-9.97%
14,870.65AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryosite Stock analysis

What does Cryosite do? Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryosite stock

Profit per Employee of Cryosite is 65,735.29 AUD in 2026.

Profit per Employee of Cryosite changed from 55,411.76 AUD to 65,735.29 AUD, representing a 18.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Cryosite since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Cryosite historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cryosite

All Key Metrics — Cryosite